AstraZeneca PLC
AZN
184.38−1.10 (−0.59%)Nov 12, 7:00 PM ET
Key stats
- Open
- 185.47
- Day high
- 185.85
- Day low
- 183.87
- Previous close
- 185.48
- Volume
- 1.71M
- VWAP
- 184.62
- 52-week high
- 212.71
- 52-week low
- 153.41
- Market cap
- 287.66B
- Shares out
- 1.55B
- Employees
- 96,100
- Listed
- 2009
About AstraZeneca PLC
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
Options · expiring Nov 20
Nov 12, 4:00 PM ET- Call open interest
- 9.6K
- Put open interest
- 5.3K
- Put/call
- 0.55
- At-the-money IV
- 24.0%
| Contract | Last | Traded | Volume | Open int. | IV |
|---|---|---|---|---|---|
| 185 call | 2.45 | Nov 12, 1:59 PM | 57 | 718 | 24.0% |
| 185 put | 3.10 | Nov 12, 2:14 PM | 52 | 576 | 29.6% |
| 195 put | 5.60 | Nov 5, 10:06 AM | 47 | 61 | 36.0% |
| 195 call | 0.25 | Nov 12, 2:16 PM | 40 | 244 | 26.5% |
| 180 put | 0.98 | Nov 12, 3:15 PM | 37 | 144 | 28.4% |
| 190 call | 1.05 | Nov 12, 3:35 PM | 23 | 710 | 24.9% |
Quarterly results
Massive · Jul 28, 2016| Q2 2016 to Jun 30, 2016 | Q1 2016 to Mar 31, 2016 | Q4 2015 to Dec 31, 2015 | Q3 2015 to Sep 30, 2015 | |
|---|---|---|---|---|
| Revenue | $5.60B | $6.12B | $6.40B | $5.95B |
| Gross profit | $4.45B | $5.04B | $5.03B | $4.83B |
| Operating income | $303.00M | $1.04B | $1.09B | $1.17B |
| Net income | −$3.00M | $646.00M | $808.00M | $770.00M |
| Diluted EPS | 0.00 | 0.51 | 0.64 | 0.60 |
| Operating cash flow | $181.00M | $1.19B | $571.00M | $1.75B |
Technicals
Massive · Nov 12, 2026- 50-day average168.41
- 200-day average180.19
- RSI (14 days)62.0
Short interest
Massive · Oct 30, 2026- Oct 30, 20263.03M shares · 1.0 days to cover
- Oct 15, 20263.28M shares · 1.1 days to cover
- Sep 30, 20262.62M shares · 1.0 days to cover
- Sep 15, 20262.09M shares · 1.0 days to cover
Dividends
Massive · Aug 7, 2026- Ex Aug 7, 2026, paid Sep 8, 20260.7950 · 2 a year
- Ex Feb 20, 2026, paid Mar 23, 20261.5950 · 2 a year
- Ex Aug 8, 2025, paid Sep 8, 20250.5150 · 2 a year
- Ex Feb 21, 2025, paid Mar 24, 20251.0500 · 2 a year
- Ex Aug 9, 2024, paid Sep 9, 20240.5000 · 2 a year
- Ex Feb 22, 2024, paid Mar 25, 20240.9850 · 2 a year
- Ex Aug 10, 2023, paid Sep 11, 20230.4650 · 2 a year
- Ex Feb 23, 2023, paid Mar 27, 20230.9850 · 2 a year
Splits
Massive · Feb 2, 2026- Feb 2, 20261-for-2
- Jul 27, 20152-for-1
Related companies
MassiveNews coverage
No stories about AstraZeneca PLC right now.